Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CDK9 keeps RNA polymerase II on track
Sylvain Egloff
Cellular and Molecular Life Sciences (2021)
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

P-TEFb: The master regulator of transcription elongation
Koh Fujinaga, Fang Huang, B. Matija Peterlin
Molecular Cell (2023) Vol. 83, Iss. 3, pp. 393-403
Open Access | Times Cited: 83
Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer
Takahiko Murayama, Jun Nakayama, Xinpei Jiang, et al.
Cancer Discovery (2024) Vol. 14, Iss. 3, pp. 468-491
Open Access | Times Cited: 30
Pan-cancer proteogenomics expands the landscape of therapeutic targets
Sara R. Savage, Xinpei Yi, Jonathan T. Lei, et al.
Cell (2024) Vol. 187, Iss. 16, pp. 4389-4407.e15
Open Access | Times Cited: 25
Design, synthesis and biological evaluation of dual CDK9/PARP inhibitors for the treatment of cancer
Jindi Huang, Ya He, Sumeng Chen, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117367-117367
Closed Access | Times Cited: 2
Design, Synthesis and Biological Evaluation of Novel 9H Purine Derivatives as Potent CDK9 Inhibitors
Chunlei Tang, Dong Wang, Huabing Wang, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 2
Closed Access | Times Cited: 1
Mechanisms and Functions of the RNA Polymerase II General Transcription Machinery during the Transcription Cycle
Stephen R. Archuleta, James A. Goodrich, Jennifer F. Kugel
Biomolecules (2024) Vol. 14, Iss. 2, pp. 176-176
Open Access | Times Cited: 6
Transcriptional elongation control of hypoxic response
Shimaa Soliman, Marta Iwanaszko, Bin Zheng, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 15
Open Access | Times Cited: 6
BRD4: a general regulator of transcription elongation
Elisabeth Altendorfer, Yelizaveta Mochalova, Andreas Mayer
Transcription (2022) Vol. 13, Iss. 1-3, pp. 70-81
Open Access | Times Cited: 25
Cyclin-dependent kinases in cancer: Role, regulation, and therapeutic targeting
Ashna Gupta, Gunjan Dagar, Ravi Chauhan, et al.
Advances in protein chemistry and structural biology (2023), pp. 21-55
Closed Access | Times Cited: 15
Super-enhancers complexes zoom in transcription in cancer
MengTing Wang, Qingyang Chen, ShuJie Wang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 14
ERK2 stimulates MYC transcription by anchoring CDK9 to the MYC promoter in a kinase activity–independent manner
Lorena Agudo‐Ibáñez, Marta Morante, Lucía García-Gutiérrez, et al.
Science Signaling (2023) Vol. 16, Iss. 794
Closed Access | Times Cited: 13
Cyclin‐dependent kinases: Masters of the eukaryotic universe
Aleksandra J. Pluta, Cécilia Studniarek, Shona Murphy, et al.
Wiley Interdisciplinary Reviews - RNA (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Emerging roles of the Protein Phosphatase 1 (PP1) in the context of viral infections
Pedro O. Corda, Mathieu Bollen, Daniela Ribeiro, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Cartilage stem/progenitor cells‐derived exosomes facilitate knee cartilage repair in a subacute osteoarthritis rat model
Jing Chen, Xiaohui Ni, Jian Yang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 5
YX0798 Is a Highly Potent, Selective, and Orally Effective CDK9 Inhibitor for Treating Aggressive Lymphoma
Changying Jiang, Yu Xue, Hong Kim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Differences in gene expression between high and low tolerance rainbow trout (Oncorhynchus mykiss) to acute thermal stress
Leah A. Turner, Anne A. Easton, Moira M. Ferguson, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0312694-e0312694
Open Access
NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia
Qing Zhu, Jia Cheng, Yuqing Gao, et al.
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access
Targeted degradation of CDK9 potently disrupts the MYC-regulated network
Mohammed A. Toure, Keisuke Motoyama, Yichen Xiang, et al.
Cell chemical biology (2025)
Open Access
Cyclin-dependent kinases as mediators of aberrant transcription in prostate cancer
Razia Rahman, Luke A. Selth
Translational Oncology (2025) Vol. 55, pp. 102378-102378
Closed Access
An eRNA transcription checkpoint for diverse signal-dependent enhancer activation programs
L. Wang, Wei Yuan, Amir Gamliel, et al.
Nature Genetics (2025)
Closed Access
Dynamic O-GlcNAcylation and phosphorylation attract and expel proteins from RNA polymerase II to regulate mRNA maturation
Aishwarya Gondane, Harri M. Itkonen
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Design, synthesis, and biological evaluation of novel 4,4′-bipyridine derivatives acting as CDK9-Cyclin T1 protein-protein interaction inhibitors against triple-negative breast cancer
Gui‐Ping Gao, Jiayi Li, Yin Cao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115858-115858
Closed Access | Times Cited: 12
A patent review of PRMT5 inhibitors to treat cancer (2018 - present)
Jing Gao, Jie Yang, Shengyu Xue, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 4, pp. 265-292
Closed Access | Times Cited: 11
Cyclin-dependent kinase 4 and 6 in cancer: Exploration of CDK4/6 inhibitors as anticancer agents
Nilay Kumar Nandi, Chahat, Rohit Bhatia, et al.
Elsevier eBooks (2024), pp. 115-137
Closed Access | Times Cited: 4
Combination therapy and dual-target inhibitors based on cyclin-dependent kinases (CDKs): Emerging strategies for cancer therapy
Qi Hao, Wenzhe Zhao, Zhijia Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117465-117465
Closed Access
Page 1 - Next Page

Scroll to top